USPTO, AbbVie, Amgen, ITC, design patents – the week in IP

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

USPTO, AbbVie, Amgen, ITC, design patents – the week in IP

October 04 2017
uspto.jpg

Recent intellectual property news included a proposal to make the USPTO an independent agency, a record year for US patent issuance, a settlement of AbbVie and Amgen’s Humira biosimilar dispute, a surge of complaints at the International Trade Commission, and the first post-Samsung verdict on design patent damages

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

TrademarksUnited StatesPatentsNorth AmericaJurisdictions
more from across site and SHARED ros bottom lb

More from across our site

Patents
Richard-de-Bodo_Bio-Pic-500x (2) (1).png
Post ‘big law’ stage: why Barton’s latest partner is keen to offer ‘something better’
Richard de Bodo, who had a lengthy career at international firms, shares how he will address client needs and praises the unique offerings of smaller firms
Sanjana Mishra, May 15 2026
Patents
Entrance to the Royal Court of Justice
This week on MIP: UK TM licensing ruling reversed | Dua Lipa sues Samsung
An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
May 15 2026
Patents
Blick auf die Business Bay in Dubai mit den modernen Wolkenkratzern bei Sonnenaufgang
Weekly take: Why AIPPI and INTA’s Dubai problem can’t be easily fixed
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Max Walters, May 14 2026
Trademarks
Lazar Raynal.png
King & Spalding scores largest ever Lanham Act award
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
Sanjana Mishra, May 14 2026
Patents
pharma-min.jpeg
BMS and Hengrui Pharma sign $15.2bn deal as patent cliff nears
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Sukanya Sarkar, May 13 2026
Patents
close-up-of-nokia-headquarters-in-espoo-finland_0 (1).jpg
Pro-arbitration turn? Appeals court stays FRAND case against Nokia
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Max Walters, May 13 2026
Trademarks
london
Abion’s UK founders depart in quick succession
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
May 13 2026
Trademarks
Magnifying glass emphasizing one glowing figure among group symbolizing focused hiring
Familiar faces: Hoyng expands with double August Debouzy hire
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
May 11 2026
Trademarks
The Royal Courts of Justice, London.
Court of Appeal overturns unjustified threats injunction in vape TM dispute
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
May 08 2026
Patents
ALMERIA, SPAIN - 02 APRIL 2023 A bronze statue of John Lennon sitting and playing the guitar in the Plaza de las Flores in Almeria, Spain
This week on MIP: Samsung to pay ZTE $392m | Lennon v Lemon TM dispute
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
May 08 2026
Gift this article